![]() OBJECTIVE: To evaluate the reliability of SMARTeZ elastomeric pump to deliver 5-FU, by measuring the percentage of pumps that deliver >90% of expected 5-FU dose at the end of 46 hours of infusion. 6 However, more than 24% of the pumps had remaining fluid of >10%, suggesting insufficient delivery of the elastomeric pumps. ![]() ![]() Recently, Cusano and colleagues showed the feasibility to monitor 5-FU delivery via Baxter elastomeric pump by comparing pump weights before and after infusion. A quantitative method to assess the delivery of 5-FU via an elastomeric pump is in great need. 5 Visual inspection, as recommended in the package insert, is not reliable. 3,4 Monitoring drug delivery by the pump is essential to treatment efficiency and drug safety. 1,2 However, the infusion rate of elastomeric pumps is affected by environmental and patient factors. Presenter: Quan Li, PharmD, BCOP, BCPS, Clinical Coordinator, MedStar Washington Hospital Center, Washington, DCĬo-Author: Alice Beers, BSN, OCN, NPD-BC, MedStar Washington Hospital Center, Washington, DCīACKGROUND: Continuous infusion of fluorouracil (5-FU) is often used in the treatment of gastrointestinal (GI) malignancies through an ambulatory infusion pump. Gastrointestinal Cancer Monthly Minutes.Advances in Dual Immunotherapy Cancer Treatments.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |